Printer Friendly

Browse Gadolinium topic


1-34 out of 34 article(s)
Title Author Type Date Words
IQ-AI subsidiary Imaging Biometrics achieves significant milestone in development of zero percent Gadolinium-based contrast agent. Sep 5, 2020 373
Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging. Zhang, Hong; Tang, Xiaolu; Lv, Yanqiu; Hu, Di; Sun, Jihang; Wang, Yan; Zhou, Jinyuan; Peng, Yun Jun 30, 2020 8076
Empirical and Theoretical Characterization of the Diffusion Process of Different Gadolinium-Based Nanoparticles within the Brain Tissue after Ultrasound-Induced Permeabilization of the Blood-Brain Barrier. Conti, Allegra; Magnin, Reemi; Gerstenmayer, Matthieu; Tsapis, Nicolas; Dumont, Erik; Tillement, Oli Dec 31, 2019 9564
IQ-AI's David Smith on the 'immense market' for its gadolinium free imaging product. Jul 31, 2019 189
Bayer wins US FDA approval for Gadato to assess myocardial perfusion and late gadolinium enhancement in adult patients with CAD. Jul 16, 2019 282
Bayer wins US FDA approval for Gadato to assess myocardial perfusion and late gadolinium enhancement in adult patients with CAD. Jul 16, 2019 278
Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model. Wang, Shu-ting; Hua, Zheng-xu; Fan, Dong-xiao; Zhang, Xin; Ren, Ke May 31, 2019 6600
The Gadolinium Controversy--An Update. Blaurock-Busch, E. Report May 1, 2019 3103
Radiofrequency ablation of an osteoid osteoma of the metacarpal. Bailey, Ryan; Siesener, Nathan J.; Davis, Ryan M.; Brogan, David M. Report Jan 1, 2019 1347
Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up. Takahashi, Edwin A.; Kallmes, David F.; Mara, Kristin C.; Harmsen, William S.; Misra, Sanjay Report Nov 1, 2018 4781
Study from Children's Hospital Los Angeles Shows Gadolinium Deposition in the Brain is Not Dose Dependent. May 17, 2018 282
A Study and Comparison of the Preparation of Gadolinium Aluminate Nanoparticles Using [gamma]-Irradiated and Unirradiated Precursors. Muhimeed, Tehani I. Al-; Kahtani, Abdullah A. Al-; Mahfouz, Refaat M.; Khan, Mujeeb; Siddiqui, M. Ra Jan 1, 2018 4106
Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy. Amano, Yasuo; Suzuki, Yasuyuki; Yanagisawa, Fumi; Omori, Yuko; Matsumoto, Naoya Jan 1, 2018 3516
Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production. Weng, Te-I.; Chen, Huang Jen; Lu, Chen-Wen; Ho, Yu-Chin; Wu, Jia-Lun; Liu, Shing-Hwa; Hsiao, Jong-Ka Jan 1, 2018 6118
Functionalization of Gadolinium Chelates Silica Nanoparticle through Silane Chemistry for Simultaneous MRI/[sup.64]Cu PET Imaging. Tran, Vu-Long; Thakare, Vivek; Natuzzi, Marco; Moreau, Mathieu; Oudot, Alexandra; Vrigneaud, Jean-Ma Jan 1, 2018 7498
Retention of gadolinium-based contrast agents. Robbins, Karen C. May 1, 2017 455
Study on the Effect of [gamma]-Irradiation on Gadolinium Oxysulfide Nanophosphors ([Gd.sub.2][O.sub.2]S-NPs). Hasim, Muhammad Hassyakirin; Rahman, Irman Abdul; Rahim, Sapizah; Ayob, Muhammad Taqiyuddin Mawardi; Jan 1, 2017 3842
Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations. Granata, Vincenza; Cascella, Marco; Fusco, Roberta; dell'Aprovitola, Nicoletta; Catalano, Orlando; F Jan 1, 2016 4600
An elaboration on the analysis of surface effects on the optical and structural properties of GD2O3 and Gd2O3:Eu3+ sol-gel films. Abstract Apr 1, 2014 127
Synthesis, characterization, and thermal kinetics of mixed gadolinium: calcium heptamolybdate system. Koul, R.K.; Suri, Shivani; Singh, Vishal; Bamzai, K.K. Report Jan 1, 2014 5570
Reexamination of nuclear shape transitions in gadolinium and dysprosium isotopes chains by using the geometric collective model. Khalaf, A.M.; Aly, H.F.; Zaki, A.A.; Ismail, A.M. Report Jan 1, 2014 2548
Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media. Ngoya, P.S.; Vawda, Z.; Lotz, J.W. Aug 1, 2013 1102
Selection of candidates for cardiac resynchronization therapy: late gadolinium enhanced cardiac magnetic resonance as a new and promising predictor of intraventricular dyssynchrony/Kardiyak resenkronizasyon tedavisi adaylarinin secimi: Intraventrikuler dissenkroninin yeni ve umit verici ongordurucusu olarak gec gadolinyum tutulumlu kardiyak manyetik rezonans. Gurel, Emre; Tigen, Kursat May 1, 2011 4447
Gadolinium and kidney disease: are your patients at risk? Hollister, Debra Clinical report Mar 1, 2008 1487
FDA requests warning for MR contrast agents. Brief article Aug 1, 2007 184
Nephrogenic systemic fibrosis risk leads to boxed warning for contrast agents. Mechcatie, Elizabeth Jun 15, 2007 555
MR contrast agent implicated in serious skin condition. Feb 1, 2007 422
MR contrast agent poses danger in renal disease. Dixon, Bruce K. Feb 1, 2007 951
New MRI aids early detection. Oct 1, 2005 330
C[O.sub.2], gadolinium provide alternative contrast options to iodine for blood vessels. Zoler, Mitchel L. Jun 15, 2005 536
MRI useful in identification of heart failure causes: cardiomyopathy assessment. Jancin, Bruce Apr 15, 2004 596
Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. Kang, Hyunseok Peter; Scott, Mitchell G.; Joe, Bonnie N.; Narra, Vamsi; Heiken, Jay; Parvin, Curtis Apr 1, 2004 3088
Enhancement along the facial nerve on MRI. Valvassori, Galdino Oct 1, 2000 245
Gadolinium: highlighting MRI: key to revelation? Shaw, Phyllis Jun 22, 1990 838

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters